Severe Systemic Arthralgia After Zoledronic Acid Infusion in a Patient With Thyroid Dysfunction and Osteoporosis. [PDF]
Kpughur-Tule MP +5 more
europepmc +1 more source
Drug-Induced Liver Injury After Zoledronic Acid Infusion and Literature Review. [PDF]
Boldt C, Prasad P, Lu H.
europepmc +1 more source
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
D. Black +20 more
semanticscholar +1 more source
Zoledronic acid and denosumab are associated with similar fracture incidence and mortality in patients with type 2 diabetes: a population-based cohort study. [PDF]
Rouach V +4 more
europepmc +1 more source
Denosumab versus zoledronic acid in metastatic breast cancer: A retrospective observational analysis of 24-dose regimens on analgesia and skeletal-related event prevention. [PDF]
Massa G +11 more
europepmc +1 more source
Zoledronic acid in metastatic castrate-sensitive prostate cancer: A state-of-the-art review. [PDF]
Damaj N +4 more
europepmc +1 more source
Doxycycline Enhances Anticancer Activity of Zoledronic Acid via Inducing ROS and Autophagy in Osteosarcoma Cell Lines. [PDF]
Li YA +7 more
europepmc +1 more source
Bilateral Knee Effusions Secondary to Zoledronic Acid Infusion. [PDF]
Wei J, Cho CSI.
europepmc +1 more source
Corrigendum: Therapeutic effects of zoledronic acid-loaded hyaluronic acid/polyethylene glycol/nano-hydroxyapatite nanoparticles on osteosarcoma. [PDF]
Xu Y, Qi J, Sun W, Zhong W, Wu H.
europepmc +1 more source

